Governing xenotransplantation in low- and middle-income countries: A ten-domain ethical and regulatory framework for clinical translation

Xenotransplantation is advancing toward routine clinical application at a pace that the ethical and regulatory apparatus designed to govern it has struggled to match.The recent implantation of genetically engineered porcine kidneys into living human recipients has established that the procedure can succeed technically; whether it can be sustained responsibly over the long term, above all in low-and middle-income countries (LMICs), turns on governance questions that reach well beyond technical safety.Anchored in the World Health Organization guiding principles and the Declaration of Istanbul, we propose a multi-dimensional ethical framework organised around ten governance domains: Iterative appraisal of benefit and risk under layered scientific uncertainty; preclinical rigour and recipient eligibility; prospective, population-level surveillance for xenozoonotic pathogens such as porcine endogenous retroviruses, instituted before clinical activity commences rather than in reaction to it; independent oversight of commercial participation, so that equitable access is protected and monopolistic control forestalled; transparent allocation designed to work alongside, never against, existing donor programmes; stewardship of biological materials; consent and community engagement calibrated to cultural and religious context; elevated thresholds for paediatric and vulnerable populations; financial and policy feasibility; and transparency with public accountability.Brought to bear on resource-constrained settings, the framework further engages the vulnerabilities peculiar to LMICs, among them fragile infrastructure, exposure to exploitation, and reliance on living donation.We propose concrete governance adaptations to ensure that early clinical xenotransplantation strengthens global transplant equity rather than enlarging the divides that already exist.

Authors

Institutions

Publication Details

Journal
World Journal of Transplantation
Published
2026-11-16
DOI
https://doi.org/10.5500/wjt.127750
Primary Topic
Xenotransplantation and immune response
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Governing xenotransplantation in low- and middle-income countries: A ten-domain ethical and regulatory framework for clinical translation

Pranjal Kashiv, Khushboo Saxena, Sweety Pasari, Manish Ramesh Balwani et al.
2 links
World Journal of Transplantation
Xenotransplantation and immune response
article

Governing xenotransplantation in low- and middle-income countries: A ten-domain ethical and regulatory framework for clinical translation

Pranjal Kashiv, Khushboo Saxena, Sweety Pasari, Manish Ramesh Balwani, Vivek B Kute, Amit Pasari, Priyanka Tolani
article en

Abstract

Xenotransplantation is advancing toward routine clinical application at a pace that the ethical and regulatory apparatus designed to govern it has struggled to match.The recent implantation of genetically engineered porcine kidneys into living human recipients has established that the procedure can succeed technically; whether it can be sustained responsibly over the long term, above all in low-and middle-income countries (LMICs), turns on governance questions that reach well beyond technical safety.Anchored in the World Health Organization guiding principles and the Declaration of Istanbul, we propose a multi-dimensional ethical framework organised around ten governance domains: Iterative appraisal of benefit and risk under layered scientific uncertainty; preclinical rigour and recipient eligibility; prospective, population-level surveillance for xenozoonotic pathogens such as porcine endogenous retroviruses, instituted before clinical activity commences rather than in reaction to it; independent oversight of commercial participation, so that equitable access is protected and monopolistic control forestalled; transparent allocation designed to work alongside, never against, existing donor programmes; stewardship of biological materials; consent and community engagement calibrated to cultural and religious context; elevated thresholds for paediatric and vulnerable populations; financial and policy feasibility; and transparency with public accountability.Brought to bear on resource-constrained settings, the framework further engages the vulnerabilities peculiar to LMICs, among them fragile infrastructure, exposure to exploitation, and reliance on living donation.We propose concrete governance adaptations to ensure that early clinical xenotransplantation strengthens global transplant equity rather than enlarging the divides that already exist.

World Journal of Transplantation
Institute of Transplantation Sciences (IN), Datta Meghe Institute of Higher Education and Research (IN), All India Institute of Medical Sciences, Nagpur (IN)
Good health and well-being
Xenotransplantation and immune response
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon